Coagulation, fibrinolysis and bleeding after open-heart surgery

References

• Bachmann F, McKenna R, Cole E R, Najati H. The hemostatis mechanism after open-heart surgery. I. J Thorac Cardiovasc Surg 1975; 70: 76–85
   PubMed Web of Science ®Google Scholar
• Bagge L, Björk I, Saldeen T, Wallin R. Purification of a fibrinolysis inhibitor in serum from posttraumatic patients. Thrombos. Haemostasis 1978; 39: 97–108
   PubMed Web of Science ®Google Scholar
• Bagge L, Carlin G, Hjelmstedt A, et al. Fibrinolysis inhibition after a major standardized trauma. Uppsala J Md Sci 1982; 87: 55–66
   PubMed Web of Science ®Google Scholar
• Bentall H H. Fibrinolysis and bleeding in open-heart surgery. Lancet 1968; 6: 4–8
   Google Scholar
• Beurling-Harburg C, Galvan C A. Acquired decrease in platelet secretory ADP associated with increased postoperative bleeding in post-cardiopulmonary bypass patients and in patients with severe valvular heart disease. Blood 1978; 52(1)13–23
   PubMed Web of Science ®Google Scholar
• Bick R L, Smalhorst W R, Arbegast N R. Alterations of hemostasis associated with cardiopulmonary bypass. Thrombos Res 1976; 8: 285–302
   PubMed Web of Science ®Google Scholar
• Bull M H, Huse W H, Bull B S. Evaluation of tests used to monitor heparin therapy during extracorporeal circulation. Anaesthesiology 1975; 43: 346–353
   PubMed Web of Science ®Google Scholar
• Cartwright G E. Diagnostic laboratory hematology4th ed. Grune and Stratton, New York 1968; 387–388
   Google Scholar
• Cullman W, Müller N, Lie T B, Kladetzky R G, Jürgens P. Coagulation parameters and heparin levels in open-heart surgery. Res Exp Med (Berl) 1980; 177: 111–117
   PubMedGoogle Scholar
• Edmunds L H, Jr, Ellison N, Colman R W, et al. Platelet function during cardiac operation. J Thorac Cardiovasc Surg 1982; 83: 805–812
   PubMed Web of Science ®Google Scholar
• Ekert H, Montgomery D, Aberdeen E. Fibrinolysis during extracorporeal circulation. Circ Res 1971; 28: 512–517
   Web of Science ®Google Scholar
• Gans H, Krivit W. Problems in hemostasis during open heart surgery IV. Ann Surg 1962; 155: 353–359
   PubMed Web of Science ®Google Scholar
• Harker L A, Malpass T W, Branson H E, Hessel E A, Slichter S J. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective α-granule release. Blood 1980; 56(5)824–834
   PubMed Web of Science ®Google Scholar
• Hattersley P G. Activated coagulation time of whole blood. JAMA 1966; 196: 436–440
   PubMed Web of Science ®Google Scholar
• Hellem A J. Platelet adhesiveness in von Willebrand's disease: A study with a new modification of the glass beads method. Scand J Med 1970; 7: 374–382
   Google Scholar
• Kalter R D, Saul C M, Wetstein L, Soriano C, Reiss R F. Cardiopulmonary bypass: Associated hemostatic abnormalities. J Thorac Cardiovasc Surg 1979; 77(3)427–435
   PubMed Web of Science ®Google Scholar
• Kladetzky R G, Popov-Cenić S, Büttner W, Müller N, Egli H. Studies of fibrinolytic and coagulation factors during open heart surgery: I. Fibrinolytic problems during open heart surgery with ECC. Thrombos Res 1975; 7: 579–588
   PubMed Web of Science ®Google Scholar
• Lambert C J, Marengo-Rowe A J, Lereson J E, et al. The treatment of post-perfusion bleeding using ε-amino-caproic acid, cryoprecipitate, freshfrozen plasma and protamine sulfate. Ann Thor Surg 1979; 2815: 440–444
   Google Scholar
• Langley P G, Hughes R D, Williams R. Platelet adhesiveness to glass beads in liver disease. Acta Haematol 1982; 67: 124–127
   PubMed Web of Science ®Google Scholar
• Laurell C B. Electroimmunoassay. Scand J Clin Lab 1972; 29: 21–37
   Google Scholar
• McKenna R, Bachmann F, Whittaker B, Gilson J R, Weinburg M. The hemostatic mechanism after open-heart surgery. II. J Thorac Cardiovasc Surg 1975; 70: 298–308
   PubMedGoogle Scholar
• Mancini G, Carbonara A O, Heremans J F. Immunochemical quantitation of antigens by single radial immunodiffusion. Int J Immunochemistry 1965; 2: 235–254
   PubMedGoogle Scholar
• Mattox K L, Guinn G A, Rubio P H, Beall A C, Jr. Use of activated coagulation time in intragenerative heparin reversed for cardiopulmonary bypass. Ann Thorac Surg 1975; 19: 634–638
   PubMed Web of Science ®Google Scholar
• Morian M, Masure R, Hurlet A, et al. Haemostasis disorders in open-heart surgery with extracorporeal circulation. Vox Sang 1977; 32: 41–51
   PubMed Web of Science ®Google Scholar
• Müller N, Popov-Cenic S, Büttner W, Kladetzky R G, Egli H. Studies of fibrinolytic and coagulation factors during open heart surgery. II. Postoperative bleeding tendency and changes in the coagulation system. Thrombos Res 1975; 7: 589–598
   PubMed Web of Science ®Google Scholar
• Nilsen N Ö. Coagulation problems during cardio-pulmonary bypass. Acta Chir Scand 1961; 122: 224–225
   PubMedGoogle Scholar
• Nilsen N Ö, Christensen A. The influence of extracorporeal circulation combined with hypothermia on the thrombocytes. Acta Chir Scand 1964; 127: 297–302
   PubMedGoogle Scholar
• Nilsson I M, Olow B. Determination of fibrinogen and fibrinolytic activity. Thrombos Diathes Haemorrh (Stuttg) 1962; 81: 297–310
   Google Scholar
• Paraskevas M, Nilsson I M, Martinsson G. A method for determining serum inhibitors of plasminogen activation. Scand J Clin Invest 1962; 14: 138–144
   PubMed Web of Science ®Google Scholar
• Peterson K A, Dewanjee M K, Kaye M P. Fate of indium m-labeled platelets during cardiopulmonary bypass performed with membrane and bubble oxygenators. J Thorac Cardiovasc Surg 1982; 84: 39–43
   PubMed Web of Science ®Google Scholar
• Pifarré R, Babka R, Sullivan H J, Motoya A, Bakhos M, El Etr A. Management of postoperative heparin rebound following cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981; 81: 378–381
   PubMed Web of Science ®Google Scholar
• Schmidt P J, Peden J C, Brecker G, Baranowsky A. Thrombocytopenia and bleeding tendency after extracorporeal circulation. N Engl J Med 1961; 265: 1181–1185
   PubMed Web of Science ®Google Scholar
• Triplett D S, Harms C, Huseby R M, Mitchell G A, Pochron S P. Clinical studies of the use of fluorogenic substrate assay method for determination of plasminogen. VII Int Congr Thromb Haemostas (Abst 0106). Thromb Haemotas 1979; 42: 50
   Google Scholar
• Verstraete M, Amery A, Vermylen C. Blood coagulation problems during extracorporeal circulation in man. Chemotherapia 1961; 3: 364
   PubMedGoogle Scholar
• Walker I D, Davidsson J F, Hutton I. “Fibrinolytical potential.” The response to a 5 minute venous occlusion test. Thrombos Res 1976; 8: 629–638
   PubMed Web of Science ®Google Scholar
• Wallin R, Bagge L, Saldeen T. Viewpoints on a clot lysis method for determination of fibrinolysis inhibition. Forensic Sci 1977; 10: 154–156
   Google Scholar